We are offering tests for antibodies in people experiencing psychosis symptoms through the Prevalence of Pathogenic Antibodies in Psychosis 2 study (PPiP2)
Those who may be eligible to take part in our study will be:
- Experiencing a current episode of psychosis lasting less than 2 years. This can be a first episode or relapse
- 16-60 years
Getting in touch
If this is you or someone you know who is receiving treatment from an NHS Mental Health Trust, details of who to contact in your local area are listed below*. This will enable you to contact the relevant PPiP2 Study Team.
Enquiries from outside UK
If you are not a UK resident you can find more information by visiting the Autoimmune Encephalitis Alliance website by clicking here.
We would not advise testing for antibodies in someone who is well and not experiencing any symptoms of psychosis. This is because we would not expect the antibodies to be positive. Even if they were present we wouldn’t offer the immune treatment, as it would be difficult to measure whether or not the treatment was helping the person.
|If you want to know more about this condition click the blue icon on the left to access an information booklet about antibody-associated psychosis.|
IF YOU DO NOT HAVE ACCESS TO EMAILS, PLEASE CALL US AT ONE OF THE NUMBERS BELOW:
CONTACT PPiP2 CENTRAL RESERACH TEAM
Isobel Harrison (07772972225)
Research Fellow/Senior Research Nurse
Iona Cairns, (07929784737)
Senior Research Assistant
Louise Wright (01865 613175)
NHS Trusts participating in our screening (PPiP2) study
Click on the name of your region to be put in contact with your local PPiP2 research team.
Regions shaded green are not currently involved in the study.
Important: please use ‘PPiP2 study query’ as the Subject of your email.
|© SINAPPS2 (2021)|